Steve Savinoff
Epilepsy · Parker, CONPI 1114546058
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,345 of the $3,820 with a category attached, or 87.6%. 28 manufacturers reported payments, led by Neuropace, Inc. at 45.5% of the total. 2025 is the largest year on record at $1,904, more than ten times the $150 reported in 2023.
Across 82 payments — averaging $46.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuropace, Inc.$2K
- AbbVie$388
- Livanova USA, Inc.$314
- SK Life Science, Inc.$227
- Neurocrine Biosciences, Inc.$152
- Jazz Pharmaceuticals Inc.$96
- plus $905 from 22 others
What the payments were for
- Travel & lodging$47512%
- Food & beverage$3,34588%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuropace, Inc. | 7 | $1,738 |
| AbbVie | 20 | $388 |
| Livanova USA, Inc. | 4 | $314 |
| SK Life Science, Inc. | 5 | $227 |
| Neurocrine Biosciences, Inc. | 6 | $152 |
| Jazz Pharmaceuticals Inc. | 1 | $96 |
| Teva Pharmaceuticals USA, Inc. | 2 | $87 |
| Neurelis, Inc. | 3 | $77 |
| Johnson & Johnson | 3 | $69 |
| Lilly USA, LLC | 3 | $65 |
| Sanofi | 2 | $60 |
| Lundbeck LLC | 3 | $60 |
| AstraZeneca(2 entities) | 3 | $58 |
| Bristol Myers Squibb | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| Novartis | 2 | $35 |
| UCB, Inc. | 1 | $30 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| Argenx US, Inc. | 1 | $29 |
| Ipsen Biopharmaceuticals, Inc | 1 | $29 |
| EMD Serono, Inc. | 1 | $29 |
| Cycle Pharmaceuticals Inc | 1 | $25 |
| Genentech USA, Inc. | 1 | $25 |
| CSL Behring | 1 | $23 |
| Biogen | 1 | $17 |
| Tanabe Pharma America, Inc. | 1 | $17 |
| Pfizer | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,820 in reported general payments places this provider in the 75th percentile of 28 epilepsy providers in Colorado.
Other epilepsy in Parker
- Kelly KnuppAurora$39K
- Danielle McDermottDenver$31K
- Charles LivseyEnglewood$29K
- Scott DemarestAurora$15K
- Chalita AtallahGreenwood Village$9K
- Jacob PellinenAurora$6K
- Jared WoodwardAurora$3K
- Samuel DestefanoLittleton$3K
- Megan AbbottAurora$2K
- Naveed ChaudhryAurora$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.